Browse Category

NASDAQ:ALAB 2 October 2025 - 20 November 2025

Astera Labs (ALAB) Surges on New BNP Paribas Coverage as Azure CXL Deal Highlights AI Momentum – 20 November 2025

Astera Labs (ALAB) Surges on New BNP Paribas Coverage as Azure CXL Deal Highlights AI Momentum – 20 November 2025

Astera Labs shares surged to $158–159 in late trading Thursday after BNP Paribas Exane initiated coverage with an “Outperform” rating and a $225 price target. The move follows a strong Q3 earnings beat, with revenue up 104% year-over-year to $230.6 million and EPS of $0.49, both above Wall Street estimates. Intraday volume topped 1.8 million shares. The company issued bullish Q4 guidance.
20 November 2025
Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs shares surged over 12% to $191 intraday on Oct. 31, 2025, though still below their September high of $262.90. The stock rebounded after a volatile month that included a 19% drop on Oct. 15 and the Oct. 22 acquisition of aiXscale Photonics. Q2 revenue jumped 150% year-over-year to $191.9 million, beating estimates. Institutional investors hold about 60% of shares, while insiders sold over $190 million in August.
Astera Labs (ALAB) Stock Plummets After AMD-Oracle AI Deal – What Investors Should Know

Astera Labs (ALAB) Stock Plummets After AMD-Oracle AI Deal – What Investors Should Know

Astera’s stock closed at $161.55 on Oct. 15, down 19% after AMD announced a 50,000-GPU deal with Oracle, sparking concerns over competition. Q2 revenue rose 150% to $191.9 million with EPS of $0.44; Q3 revenue is guided at $203–210 million. Analysts remain mostly bullish, with 14 buys and an average price target of $187. Astera highlighted new AI connectivity partnerships at the OCP Summit.
Astera Labs Stock Soars on AI Momentum: Is This High-Flying Chip Innovator Still a Buy in 2025?

Astera Labs (ALAB) Stock Skyrockets on AI Boom – Nvidia & AMD Partnerships Fuel Frenzy

Astera Labs shares soared from $36 at IPO to a 52-week high near $262 in September 2025 before dropping 14% to around $170 on October 14. Q2 FY2025 revenue jumped 150% year-over-year to $191.9 million, with record free cash flow and over $1 billion in cash. Management guided Q3 revenue to $203–210 million. Wall Street targets range from $155 to $275, with most analysts rating the stock a “Moderate Buy.”
Astera Labs Stock Soars on AI Momentum: Is This High-Flying Chip Innovator Still a Buy in 2025?

Astera Labs Stock Explodes Over 200% — But Is the AI Connectivity Darling Priced for Perfection?

Astera Labs shares surged over 220% in six months, reaching a $33 billion market value and closing at $229 on Oct. 6 after a 14% rally. Fiscal Q2 2025 revenue jumped 150% to $191.9 million, with non-GAAP EPS at $0.44 and $1.07 billion in cash. The stock trades at over 300 times trailing earnings. Analysts’ average 12-month price target is $160, below current levels.
Astera Labs Stock Soars on AI Momentum: Is This High-Flying Chip Innovator Still a Buy in 2025?

Astera Labs Stock Soars on AI Momentum: Is This High-Flying Chip Innovator Still a Buy in 2025?

Astera Labs shares surged nearly 286% since its March 2024 IPO, hitting a high of $262.90 in September 2025 before retreating to $195 on Oct. 2. Fiscal Q2 2025 revenue jumped 150% year-over-year to $191.9 million, with net income of $51.2 million. Hedge fund FengHe Fund Management became the largest shareholder in October. Analysts remain bullish but warn of stretched valuations and volatility.
Go toTop